Your Cart Is Empty!
Taking the right dose of the right medicine at the right time is key to improving health outcomes, so why do so many patients fail to adhere to their treatment programme?
Trends and Innovations in Patient Adherenceis a thought-provoking and comprehensive report for everyone involved in ensuring patients comply with taking their medicines. The report provides extensive background information and is enriched by case studies. Most importantly, the report reveals the candid opinions of 16 leading experts from the pharma industry, health payers and patient advocacy groups in the US and Europe that present business-critical insights for pharma.
If one issue unites health payers, clinicians and the pharma industry, it is patient adherence. Clinicians want the best possible outcome for their patients, health payers need to ensure health spending is optimised and the industry wants clinical outcomes to reflect the safety and efficacy seen in trials. However a number of patients decide - for a variety of reasons - not to take their medicines as directed. The consequential cost of poor patient adherence is considerable, and changing behaviours is proving a challenge.
How can pharma improve its education and patient adherence programmes? What role can patient advocacy groups play? How do health payers assess value for money? What part could technological innovations play in modifying patient behaviour? Get answers to these questions in this new report.
- Understand the many and diverse drivers of patient non-compliance behaviour
- Formulate strategies to improve adherence in specific patient groups
- Assess the attitudes of health payers to non-adherence and identify collaborative opportunities to tackle it
- Learn of multi-functional approaches to creating effective adherence programmes
- Appreciate the importance of monitoring outcomes to support programmes and encourage use
- Understand the technical innovations that will underpin drives to improve adherence and monitoring
- Plan effective patient adherence programmes to ensure support is appropriate and sustained
Gain Answers to Critical Questions
- What is the current understanding of the clinical, social, economic and personal factors that lead to poor patient adherence?
- Is patient adherence all about the cost for health payers, and how do payers view current patient adherence programmes? How might patient non-adherence influence product strategies and research programmes?
- What are the benefits of industry, patient groups and clinicians working together to develop optimal approaches for both acute and chronic conditions?
- Digital innovations such as messaging reminders, electronic pill dispensers and smart pills can improve adherence and provide clinical feedback - where, how and when might they be used for best advantage?
- What are the critical success factors for patient adherence programmes, and how will they evolve in the near future?
- Learn the views and needs of health payers and patient groups when formulating patient education and support programmes
- Review case studies on how industry is tackling the challenges
- Identify the key behavioural drivers that lead to patient non adherence
- Appreciate how digital innovation will influence this key area of industry
- Key recommendations to maximise success of adherence programmes
- Knowledgeable and detailed "real world" opinions of 16 leading experts working daily in the patient adherence field across the US and Europe
- Illustrative case studies demonstrating different approaches
- A thought provoking assessment of the challenges for tackling patient non-compliance and how views in Europe and US differ
- Critical insights for planning, marketing, brand management and stakeholder engagement
- European medical affairs manager at a global biopharmaceutical company
- European marketing manager at a global pharmaceutical company
- Global marketing manager at a major pharmaceutical company
- Head of patient engagement, European pharmaceutical company
- Pharmacy director at a national health insurer, US
- Chief medical officer, managed care organisation (MCO), US
- Vice president of a national pharmacy benefits manager (PBM), US
- Medicines optimisation and prescribing lead at a large NHS clinical commissioning group (CCG), UK
- Pharmacy director, France
- Chief pharmacist, Italy
- Chief pharmacist, Spain
- Anonymous German KOL
Patient Opinion Leaders
- Director, European Patients Academy on Therapeutic Innovation (EUPATI)
- Board member of the European Parkinsons Disease Association (EPDA)
- Chief Executive of a myeloma support organisation
- Founder and president of online community and resource centre for cancer patients, survivors and families
About FirstWord Reports
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
- FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. FirstWord Reports provide expert views and intelligence on the challenges facing pharma today in these topic areas: Biosimilars, Market Access, Medical Affairs, Sales & Marketing, Technology, Therapy Areas.
- FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your companys success.
Learn more at www.firstwordgroup.com.
Following are different modes of Licenses.
a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.